<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03350698</url>
  </required_header>
  <id_info>
    <org_study_id>17-09-FB-0176</org_study_id>
    <nct_id>NCT03350698</nct_id>
  </id_info>
  <brief_title>Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination</brief_title>
  <official_title>Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination (Version IV Dated 24Oct2017)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eastern Virginia Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Eastern Virginia Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently there are no standards for healthcare worker vaccination with the HPV, Gardasil-9
      vaccine. For health care workers, the CDC only recommends for vaccination against hepatitis
      B, influenza virus, Measles, Mumps and Rubella (MMR), Chickenpox (Varicella), Tetanus,
      Diptheria, and Pertussis (Tdap), and meninogococcal infections6
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Initial antibody titers will be measured immediately prior to initial vaccination (month 0).
      This will entail a blood-draw sample (less than 1 teaspoon) that will be sent to FOCUS labs
      for evaluation. This will be paid for by funding received from Merck.

      The three-dose vaccination schedule will be followed with injections at month 0, 2, and 6.
      Gardasil 9 dosing will be per the recommended and approved labeled guidelines.
      Post-vaccination titers would be measured at month 7, which is in alignment with the methods
      of previous studies. This will entail a blood-draw sample (less than 1 teaspoon) that will be
      sent to FOCUS labs for evaluation.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 27, 2018</start_date>
  <completion_date type="Anticipated">November 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 14, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective Single-Subject Experimental Design</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure># of participants with elevated HPV antibody titers from baseline to 7 months</measure>
    <time_frame>baseline and 7 months</time_frame>
    <description>baseline change at 7 months post vaccine series. The antibody titer laboratory test will be used to record the levels</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Papillomavirus Vaccines</condition>
  <arm_group>
    <arm_group_label>active drug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Human Papilloma virus ,Gardasil, 9 valent vaccine</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Gardasil-9</intervention_name>
    <description>3 vaccine series</description>
    <arm_group_label>active drug</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Actively practicing attending surgeon in the field of Otolaryngology, General
             Surgery, Urology, or Obstetrics-Gynecology employed by EVMS or credentialed by CHKD
             and/or SNGH.

        or

        • Current residents of EVMS Otolaryngology, General Surgery, Urology, or
        Obstetrics-Gynecology programs

        Exclusion Criteria:

          -  • Age 26 or younger

               -  Age over 69

               -  Hypersensitivity to vaccine component

               -  History of severe allergic or hypersensitivity reactions to yeast

               -  History of previous HPV vaccination with 9 valent vaccine

               -  Pregnant

               -  Moderate or severe acute illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>27 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Craig H Derkay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eastern Virginia Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Craig H Derkay, MD</last_name>
    <phone>757-668-9842</phone>
    <email>craig.derkay@chkd.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Stone, RN</last_name>
    <phone>757-388-6238</phone>
    <email>stonelj@evms.edu</email>
  </overall_contact_backup>
  <link>
    <url>http://www.cdc.gov/std/hpv/stdfact-hpv.htm</url>
    <description>HPV fact sheet</description>
  </link>
  <link>
    <url>http://www.cdc.gov/vaccines/adults/rec-vac/hcw.html</url>
    <description>recommended vaccines for healthcare workers</description>
  </link>
  <reference>
    <citation>Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010 Aug;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6. Epub 2010 May 5. Review.</citation>
    <PMID>20451455</PMID>
  </reference>
  <reference>
    <citation>Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 Feb 6;348(6):518-27.</citation>
    <PMID>12571259</PMID>
  </reference>
  <reference>
    <citation>Dickens P, Srivastava G, Loke SL, Larkin S. Human papillomavirus 6, 11, and 16 in laryngeal papillomas. J Pathol. 1991 Nov;165(3):243-6.</citation>
    <PMID>1662265</PMID>
  </reference>
  <reference>
    <citation>Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortés ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011 Aug 26;333(6046):1157-60. doi: 10.1126/science.1208130. Epub 2011 Jul 28.</citation>
    <PMID>21798893</PMID>
  </reference>
  <reference>
    <citation>Hallmo P, Naess O. Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon. Eur Arch Otorhinolaryngol. 1991;248(7):425-7.</citation>
    <PMID>1660719</PMID>
  </reference>
  <reference>
    <citation>Calero L, Brusis T. [Laryngeal papillomatosis - first recognition in Germany as an occupational disease in an operating room nurse]. Laryngorhinootologie. 2003 Nov;82(11):790-3. German.</citation>
    <PMID>14634897</PMID>
  </reference>
  <reference>
    <citation>Makiyama K, Hirai R, Matsuzaki H. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men: First Report: Changes in HPV Antibody Titer. J Voice. 2017 Jan;31(1):104-106. doi: 10.1016/j.jvoice.2016.01.008. Epub 2016 Apr 8.</citation>
    <PMID>27068425</PMID>
  </reference>
  <reference>
    <citation>Einstein MH, Takacs P, Chatterjee A, Sperling RS, Chakhtoura N, Blatter MM, Lalezari J, David MP, Lin L, Struyf F, Dubin G; HPV-010 Study Group. Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial. Hum Vaccin Immunother. 2014;10(12):3435-45. doi: 10.4161/hv.36121.</citation>
    <PMID>25483701</PMID>
  </reference>
  <reference>
    <citation>Sehulster L, Chinn RY; CDC; HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003 Jun 6;52(RR-10):1-42.</citation>
    <PMID>12836624</PMID>
  </reference>
  <reference>
    <citation>Ilmarinen T, Auvinen E, Hiltunen-Back E, Ranki A, Aaltonen LM, Pitkäranta A. Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts. Eur Arch Otorhinolaryngol. 2012 Nov;269(11):2367-71. doi: 10.1007/s00405-012-2049-9. Epub 2012 May 16.</citation>
    <PMID>22588197</PMID>
  </reference>
  <reference>
    <citation>Garden JM, O'Banion MK, Bakus AD, Olson C. Viral disease transmitted by laser-generated plume (aerosol). Arch Dermatol. 2002 Oct;138(10):1303-7.</citation>
    <PMID>12374535</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2017</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eastern Virginia Medical School</investigator_affiliation>
    <investigator_full_name>Craig Derkay M.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Human papilloma virus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Papilloma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

